_________

C002

טבע תעשיות פרמצבטיות בע"מ

2

Public

TEVA- PHARMACEUTICAL INDUSTRIES LTD.

2529

Corporation no: 520013954

Stock Exchange/Market: טבע

310

380

P.O.B 3190 , Petach Tikva 49131 , ,

Tel: 03-9267297 , 03-9267281 Fax: 03-9267429

E.mail address: Liraz.Kalif@Teva.co.il

Date of transmission: 07/11/2006

              Time of broadcast: 14:55 14:28:20

Reference: 2006-02-127303

Israel Securities Authority		Tel Aviv Stock Exchange
www.isa.gov.il		www.tase.co.il

Immediate Report

Regulation 4 of the Securities Regulations, (Periodic and Immediate Reports of Foreign Corporation) 5761-2000

The corporation is a foreign private issuer as defined by U.S. Securities Laws.

Attached hereto is a report on Teva Reports third quarter 2006 results

Q306E071106combinedfinal_isa.pdf

Please find attached a press release announced today in the U.S. and its unofficial hebrew translation. The binding release is the english version.

References of previous documents relating to this matter(the reference does not constitute incorporation by reference):

Previous names of reporting entity:

Date of revision of form structure: 31/10/2006

Name of the Signatory: : Suesskind Dan , , Position of Signatory in the reporting corporation: Chief Financial Officer

Basel Telephone: 02-5892840 , Facsimile: 02-5892839 , E-mail: dan.suesskind@teva.co.il